Value (95% CI) | |||||
---|---|---|---|---|---|
Sensitivity | Specificity | PPV | NPV | Kappa | |
Symptomatic (N = 50)a | |||||
LM | 100.0% (85.7–100.0) | 100.0% (87.5–100.0) | 100.0% (85.7–100.0) | 98.7% (87.5–100.0) | 1.0 (1.0–1.0) |
RDT | 95.0% (76.4–99.0) | 100.0% (87.5–100.0) | 100.0% (83.2–100.0) | 96.3% (82.3–99.4) | 1.0 (0.9–1.0) |
LAMP | 100.0% (85.7–100.0) | 100.0% (87.5–100.0) | 100.0% (85.7–100.0) | 98.7% (87.5–100.0) | 1.0 (1.0–1.0) |
Asymptomatic (N = 437)a | |||||
LM | 50.0% (28.0–72.0) | 100.0% (99.1–100.0) | 100.0% (67.6–100.0) | 98.0% (96.4–99.1) | 0.7 (0.4–0.9) |
RDT | 50.0% (28.0–72.0) | 100.0% (99.1–100.0) | 100.0% (67.6–100.0) | 98.0% (96.4–99.1) | 0.7 (0.4–0.9) |
LAMP | 100.0% (80.6–100.0) | 100.0% (99.1–100.0) | 100.0% (80.6–100.0) | 100.0% (99.1–100.0) | 1.0 (1.0–1.0) |